Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

The ten-year rule revisited: accuracy of clinicians' estimates of life expectancy in patients with localized prostate cancer.

Krahn MD, Bremner KE, Asaria J, Alibhai SM, Nam R, Tomlinson G, Jewett MA, Warde P, Naglie G.

Urology. 2002 Aug;60(2):258-63.

PMID:
12137823
2.

Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer.

Walz J, Gallina A, Perrotte P, Jeldres C, Trinh QD, Hutterer GC, Traumann M, Ramirez A, Shariat SF, McCormack M, Perreault JP, Bénard F, Valiquette L, Saad F, Karakiewicz PI.

BJU Int. 2007 Dec;100(6):1254-8.

3.

Are we selecting the right patients for treatment of localized prostate cancer? Results of an actuarial analysis.

Koch MO, Miller DA, Butler R, Lebos L, Collings D, Smith JA Jr.

Urology. 1998 Feb;51(2):197-202.

PMID:
9495697
4.

Predicting life expectancy in prostate cancer patients.

Jeldres C, Latouff JB, Saad F.

Curr Opin Support Palliat Care. 2009 Sep;3(3):166-9. doi: 10.1097/SPC.0b013e32832e9c80. Review.

PMID:
19553817
5.

Do older men benefit from curative therapy of localized prostate cancer?

Alibhai SM, Naglie G, Nam R, Trachtenberg J, Krahn MD.

J Clin Oncol. 2003 Sep 1;21(17):3318-27.

PMID:
12947068
6.

Is there age bias in the treatment of localized prostate carcinoma?

Alibhai SM, Krahn MD, Cohen MM, Fleshner NE, Tomlinson GA, Naglie G.

Cancer. 2004 Jan 1;100(1):72-81.

7.

Continued undertreatment of older men with localized prostate cancer.

Schwartz KL, Alibhai SM, Tomlinson G, Naglie G, Krahn MD.

Urology. 2003 Nov;62(5):860-5.

PMID:
14624909
8.

The assessment of patient life-expectancy: how accurate are urologists and oncologists?

Wilson JR, Clarke MG, Ewings P, Graham JD, MacDonagh R.

BJU Int. 2005 Apr;95(6):794-8.

9.

United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region.

McNaughton Collins M, Barry MJ, Zietman A, Albertsen PC, Talcott JA, Walker Corkery E, Elliott DB, Fowler FJ Jr.

Urology. 2002 Oct;60(4):628-33.

PMID:
12385923
10.
11.

Predicting life expectancy in men with clinically localized prostate cancer.

Cowen ME, Halasyamani LK, Kattan MW.

J Urol. 2006 Jan;175(1):99-103.

PMID:
16406881
12.

Clinical implementation of quality of life instruments and prediction tools for localized prostate cancer: results from a national survey of radiation oncologists and urologists.

Kim SP, Karnes RJ, Nguyen PL, Ziegenfuss JY, Han LC, Thompson RH, Trinh QD, Sun M, Boorjian SA, Beebe TJ, Tilburt JC.

J Urol. 2013 Jun;189(6):2092-8. doi: 10.1016/j.juro.2012.11.174.

PMID:
23219546
13.

[Competitive morbidity ant its impact on life expectancy: evaluation and inclusion in the therapeutic decision regarding localized prostatic cancer].

Soulié M, Villers A, Richaud P, Prapotnich D, Ruffion A, Grosclaude P.

Prog Urol. 2001 Dec;11(6):1195-204. Review. French.

PMID:
11859652
14.

Treatment options for localized prostate cancer: quality-adjusted life years and the effects of lead-time.

Bhatnagar V, Stewart ST, Bonney WW, Kaplan RM.

Urology. 2004 Jan;63(1):103-9.

PMID:
14751359
15.

The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.

Wilt TJ, Brawer MK, Barry MJ, Jones KM, Kwon Y, Gingrich JR, Aronson WJ, Nsouli I, Iyer P, Cartagena R, Snider G, Roehrborn C, Fox S.

Contemp Clin Trials. 2009 Jan;30(1):81-7. doi: 10.1016/j.cct.2008.08.002.

PMID:
18783735
16.

A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer.

Walz J, Gallina A, Saad F, Montorsi F, Perrotte P, Shariat SF, Jeldres C, Graefen M, Bénard F, McCormack M, Valiquette L, Karakiewicz PI.

J Clin Oncol. 2007 Aug 20;25(24):3576-81.

PMID:
17704404
17.

Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE.

Mitchell JA, Cooperberg MR, Elkin EP, Lubeck DP, Mehta SS, Kane CJ, Carroll PR.

J Urol. 2005 Apr;173(4):1126-31.

PMID:
15758720
18.

Contemporary management of prostate cancer: a practice survey of Ontario genitourinary radiation oncologists.

Rodrigues G, D'Souza D, Crook J, Malone S, Sathya J, Morton G.

Radiother Oncol. 2003 Oct;69(1):63-72.

PMID:
14597358
19.

Accuracy of life tables in predicting overall survival in candidates for radiotherapy for prostate cancer.

Walz J, Gallina A, Hutterer G, Perrotte P, Shariat SF, Graefen M, McCormack M, Bénard F, Valiquette L, Saad F, Karakiewicz PI.

Int J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):88-94.

PMID:
17446004
20.

A critique of the decision analysis for clinically localized prostate cancer.

Beck JR, Kattan MW, Miles BJ.

J Urol. 1994 Nov;152(5 Pt 2):1894-9.

PMID:
7933246
Items per page

Supplemental Content

Support Center